Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | tridihexethyl | 7699 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | tridihexethyl | 7699 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | tridihexethyl | 7699 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | tridihexethyl | 7699 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | tridihexethyl | 7699 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | tridihexethyl | 7699 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | tridihexethyl | 7699 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | tridihexethyl | 7699 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | tridihexethyl | 7699 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | tridihexethyl | 7699 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | tridihexethyl | 7699 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | tridihexethyl | 7699 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mecamylamine | 446378 | drug-path |
| Glioma | Q9NZM4 | map05214 | mecamylamine | 446378 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | mecamylamine | 446378 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mecamylamine | 446378 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | mecamylamine | 446378 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | mecamylamine | 446378 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | mecamylamine | 446378 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | mecamylamine | 446378 | drug-path |